Biotech

FDA Clears Blood Test for Diagnosing Alzheimer’s Disease

The FDA has approved a new plasma-based biomarker assay, the first blood-based diagnostic for Alzheimer's disease, offering a less invasive and more accessible alternative to traditional methods like PET scans and spinal taps.

Cerevance Reports Phase 2 Results for Solengepras in Early-Stage Parkinson’s Disease

Cerevance has announced topline results from its Phase 2 ASCEND trial of solengepras, showing a small but non-significant improvement in motor symptoms and potential benefits for non-motor symptoms, with a strong safety profile.

AstraZeneca to Acquire EsoBiotec in $1B Deal to Drive Next-Generation Cell Therapy

AstraZeneca announces acquisition of EsoBiotec for $1 billion, aiming to advance its cell therapy capabilities with EsoBiotec's in vivo genetic programming platform for cancer and immune-mediated diseases.

Magnetic Bead Separation: More Than Just a Magnet

We sit down with Sepmag's Lluís M. Martinez, Founder & CSO, and Josep-Maria Simó, Managing Director, to discuss the current state and future of magnetic separation technology.

Immunocore Unveils Promising HIV Functional Cure Data at CROI 2025

Promising early data at CROI 2025 shows that HIV functional cure candidate, IMC-M113V, is well-tolerated and may offer prolonged viral suppression without the need for lifelong antiretroviral therapy.

11 Children Regain Sight Thanks to MeiraGTx

The leading gene therapy company, has announced positive clinical trial results for its groundbreaking gene therapy treatment aimed at restoring vision in children with inherited retinal diseases